300583.SZ
Shandong Sito Bio-technology Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 12.72
−1.32%Year over year
Reported trailing growth
- Revenue
- +10.0%
- EBITDA
- —
- EBIT
- +70.2%
- EPS
- +65.3%
- Free cash flow
- +5.6%
- Operating cash flow
- +22.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -8.1%
- EBITDA
- -24.6%
- EBIT
- +25.3%
- Net income
- +17.6%
- EPS
- +17.0%
- Free cash flow
- +262.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026